Exostar’s solutions are an enabler that supports the transformation of the drug research and development (R&D) process. Rather than go it alone, companies are embracing a partner-centric R&D model that speeds time-to-market for new drugs and therapies. Exostar’s community offering in the cloud addresses three key business tenets:
· Connect once (to access applications across enterprise boundaries)
· Collect once (to share partner attribute information with relying parties)
· Certify once (to reduce the cost of multiple audits)
The Exostar Life Sciences Identity Hub brings together organizations and their systems, applications, and information. The cloud-based Identity Hub, delivered as-a-Service, eliminates the need for companies including manufacturers, clinical research organizations, and academic institutions to establish and maintain costly, redundant point-to-point interactions, freeing critical IT resources and budgets.
SAM provides employees of connected organizations with single sign-on access, using their existing credentials, to a growing list of more than 20 enterprise-class applications both on-premise and in the cloud. SAM controls user access through strong authentication of identities, along with enforcement of the roles and privileges assigned and updated by system, application, and information owners.
Exostar teams with stakeholders in the community to define and refine the Life Science Identity Hub’s processes, rules, and governance terms that provide the flexibility and accountability necessary to ensure compliance with corporate, industry, and Government regulatory requirements, while protecting intellectual property and sensitive information from compromise. The Life Sciences service offering builds on Exostar’s expertise in delivering similar capabilities to the Aerospace and Defense marketplace, where the community encompasses nearly 100,000 organizations and 300,000 users in 150 countries.
“Our solution is allowing Life Sciences organizations to more quickly establish new relationships, strengthen existing relationships, and reduce IT costs,” said Vijay Takanti, Exostar’s Vice President of Security and Collaboration Solutions. “By reducing the time it takes these organizations to begin collaborating productively with their external partners from months to days, we are helping streamline the drug R&D process – driving new revenue streams for our customers while bringing life-altering drugs and therapies to market sooner.”
